Bioactive Coating Adhesion via Carboxylic Acid Surface Functionalization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical devices coated with bioactive agents often fail to achieve consistent and reliable coatings, leading to variable therapeutic results due to inadequate adhesion and release rates, which do not meet regulatory requirements and can cause foreign body reactions.
Innovation Solution
The method involves functionalizing the medical device surfaces with carboxylic acid to increase acidic polar components, allowing for direct application of a bioactive agent layer without containment mechanisms, enhancing adhesion and uniformity of the coating.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If a bioactive agent is applied directly to an untreated surface of a medical device, then the application process is simple, but the coating is non-uniform and unreliable
Solution Approach 1:
The surface is treated with carboxylic acid before applying the bioactive agent to create carboxyl groups that enhance adhesion. This preliminary surface modification ensures uniform and reliable coating while maintaining process simplicity.
2Reliability
If containment mechanisms are used to hold the bioactive material, then the coating adherence is improved, but the device complexity increases and additional substances are required
Solution Approach 1:
The patent removes the need for containment mechanisms by directly modifying the surface chemistry with carboxylic acid treatment. The carboxyl groups created on the surface provide sufficient adhesion for the bioactive agent without requiring additional containment layers or mechanisms.
Solution Approach 2:
Carboxylic acid acts as an intermediary substance that modifies the surface to create carboxyl groups, which then serve as binding sites for the bioactive agent. This intermediary treatment enables reliable adhesion without complex containment structures.
3Reliability
If containment mechanisms are used to control bioactive agent release, then the release rate can be managed, but the amount of bioactive material that can be carried is reduced
Solution Approach 1:
The patent eliminates containment mechanisms that limit drug loading capacity. By using carboxylic acid surface treatment to create direct adhesion sites, the device can carry higher amounts of bioactive material while still maintaining controlled release through the surface-bound coating.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in improved bioactive agent retention and uniform coating, ensuring consistent drug release and compliance with regulatory standards without the need for additional containment substances.
Implementation Method 1
functionalising the at least one surface of the structure by subjecting the at least one surface to acidification by a carboxylic acid to form at least one acid functionalised surface
Implementation Method 2
applying a bioactive agent layer directly on so as to overlie the at least one functionalised and cleaned surface
Data Source
AI summary
A medical device such as a stent or medical balloon is functionalised prior to coating with a bioactive material, specifically by carboxylic acidification of the contact surface or surfaces of the medical device. The preferred process involves washing a stent or other medical device in a washing solution which may be sodium hydroxide, soaking in a carboxylic acid solution, rinsing in water to remove excess carboxylic acid, allowing to dry before applying a bioactive agent layer. It has been found that washing after functionalisation removes excess carboxylic acid and enhances the retention of bioactive agent on the contact surface or surfaces of the medical device leading to a more uniform and consistent layer of bioactive agent.